Synairgen Share Discussion Threads

[judijudi] 10/4/2021 16:54

Nobbygnome10 Apr '21 - 14:19 - 18459 of 18466
Sadly it seems we are not going to be saved from sanctimonious rubbish.....
Stay happy JJ!

What part of “do one” are you actually struggling with?

[judijudi] 10/4/2021 16:53

tickboo10 Apr '21 - 14:09 - 18458 of 18465
0 2 0
I am sure those who didn’t need oxygen but suffered would disagree and will be interesting the long Covid results as they looks to be a big issue.

Also, even keeping people from hospital at £2k a pop is worth its weight snd one could think, especially as a it’s generic therapeutic, it will be stockpiled by hospitals all over. I’m not aware of any other therapeutics thst have had circa 80% of preventing severe disease of those hospitalised. Hopefully in the home trial no one will have been hospitalised given the early administration although you’d think a small % of placebo will have been hospitalised. The safety data also key. Should be a massive month or so for SNG as ACTIV-2 progresses, home trial results and phase 3 moves forward


My point is there are a lot more than as hazl posted “scores” of people requiring treatment. There are 1000’s

And SNG needs 1000’s if not 10’ of 1000’s to be profitable

My post is not rocket science or up for scrutiny. It’s simply the “scores of people” hazl got wrong

[judijudi] 10/4/2021 16:49

hazl,
You said scores of people
My point is there are 1000’s

[tickboo] 10/4/2021 15:57

https://link.springer.com/content/pdf/10.1007/s00134-021-06392-4.pdf

[albert arthur] 10/4/2021 15:51

We have created a channel for the Sharetalk Sunday Roast. We will be doing a weekly vote. Aiming to get CEOs on and talk about stocks people in the channel request. The chat will be open Sunday's until 8pm. This link is here: https://t.me/sharetalkroast

[tickboo] 10/4/2021 15:22

Schrow123 on Lse -Casanova Labs - interferon researchToday 14:54Highly recommend you follow these guys if you're on Twitter; they've adopted a real focus on researching the role of interferons in C-19 infection, especially early on. In doing so, they've been making the investment case for SNG better than any broker note or closed Reddit group could. This is their latest finding, again overwhelmingly favours the hypothesis that the strong interferon response is crucial to avoiding serious disease:https://twitter.com/casanova_lab/status/1380867602738728960?s=21" auto-antibodies neutralizing type I IFNs are found exclusively in C-19 patients admitted to the ICU"Basically, if your body suppresses the production of interferons, you are waaay more likely to end up seriously ill with C-19. Go figure!

[nobbygnome] 10/4/2021 14:19

Sadly it seems we are not going to be saved from sanctimonious rubbish.....

Stay happy JJ!

[tickboo] 10/4/2021 14:09

I am sure those who didn't need oxygen but suffered would disagree and will be interesting the long Covid results as they looks to be a big issue. Also, even keeping people from hospital at £2k a pop is worth its weight snd one could think, especially as a it's generic therapeutic, it will be stockpiled by hospitals all over. I'm not aware of any other therapeutics thst have had circa 80% of preventing severe disease of those hospitalised. Hopefully in the home trial no one will have been hospitalised given the early administration although you'd think a small % of placebo will have been hospitalised. The safety data also key. Should be a massive month or so for SNG as ACTIV-2 progresses, home trial results and phase 3 moves forward.

[judijudi] 10/4/2021 13:07

Scores of respiratory suffers does not make the product financially viable
It needs 1,000’s if not 10’000’s of sufferers to be financially viable
imho

[hazl] 10/4/2021 12:25

The patient will wait as has been seen by the narrow range in the last little while.
This is not a typical virus stock,it has a medication that might help scores of respiratory sufferers,in the future,in my opinion.
H